Infectious Mononucleosis: Symptoms, Causes, Treatment in Children and Adults

What is Mononucleosis?

Infectious mononucleosis, commonly known as the “kissing disease” or glandular fever, is a contagious viral illness caused by the Epstein-Barr virus (EBV). It can affect individuals of any age, but it is most prevalent among children, teenagers, and young adults, with an incubation period of approximately 4 to 6 weeks.

The hallmark symptoms of mononucleosis include:

• Sore throat
• Fever
• Severe fatigue
• Swollen lymph nodes

Although these symptoms can be quite uncomfortable, they typically resolve within 2 to 3 weeks in otherwise healthy individuals, without significant complications. However, in adults, fatigue may persist for several months.

Transmission occurs primarily through saliva. The exact duration of contagiousness has not been definitively established, though the virus is believed to remain detectable in saliva for at least 6 months after the onset of illness. Despite this, mononucleosis is generally not considered a highly contagious disease compared to other viral infections like the common cold.

Diagnosis is confirmed through specific blood tests, and treatment is symptomatic only. No antiviral drug has proven sufficiently effective for routine clinical use against EBV in uncomplicated cases.

The prognosis is excellent: the vast majority of patients recover fully and develop long-lasting immune control over the virus. Current scientific research has, however, firmly established links between EBV and certain chronic and oncological conditions, making appropriate clinical follow-up important in complex cases.

Can Mononucleosis Come Back? Recurrence

In most cases, a person contracts mononucleosis only once in their lifetime and acquires lasting immunity. However, in rare instances, symptoms may recur months or even years later.

Once infected, a person becomes a lifelong carrier of EBV, typically in a latent (dormant) state. The virus may periodically reactivate. When this occurs, it can be detected in saliva and transmitted to others, even in the complete absence of symptoms.

In rare cases, reactivated EBV can cause symptomatic illness, particularly in individuals with weakened immune systems (e.g., patients with AIDS).

An uncommon but serious outcome is Chronic Active EBV Infection (CAEBV), a rare condition defined by symptomatic disease persisting for more than six months after the initial diagnosis.

If you experience recurring symptoms such as:

• Persistent fatigue
• Weakness (asthenia)
• Fever
• Sore throat
• Swollen lymph nodes

consult your physician to identify the cause. It is important to remember that many other conditions, including viral hepatitis and toxoplasmosis, can produce symptoms clinically indistinguishable from mononucleosis.

---

Transmission and Causes

Infectious mononucleosis is caused by the Epstein-Barr virus (EBV), a member of the Herpesviridae family. This is the same viral family that includes Herpes Simplex Virus type 1 (oral herpes), type 2 (genital herpes), and Varicella-Zoster Virus, which is responsible for both chickenpox and shingles.

It is estimated that approximately 95% of the world’s adult population has been infected with EBV at some point in their lives.

The virus is transmitted primarily through saliva, via:

• Deep kissing (hence the name “kissing disease”, explaining its high prevalence among teenagers)
• Sharing food, drinks, or utensils
• Sharing toothbrushes
• Respiratory droplets from sneezing or coughing

Young children may also be infected indirectly by placing contaminated toys or objects in their mouths (the virus is believed to remain viable on a surface as long as it remains moist).

While saliva is the primary vector, EBV can technically also be transmitted through blood and semen, for example via sexual intercourse, blood transfusions, or organ transplants, although these routes are far less common.

An important concept is that of the asymptomatic carrier: a person who harbors and can transmit the virus without ever experiencing symptoms. Additionally, some individuals can shed the virus in their saliva for several months after recovery, and may intermittently become infectious again as the virus reactivates silently.

After primary infection, EBV establishes lifelong latency in B lymphocytes. In immunocompetent individuals, this latency is tightly controlled by the immune system and causes no symptoms. Reactivation may occur but rarely leads to clinically significant illness in healthy people.

---

Symptoms

The incubation period of EBV ranges from 4 to 8 weeks in adolescents and adults, and may be shorter in younger children.

Early symptoms of infectious mononucleosis typically include:

• Fever
• Headache
• Muscle aches (myalgia)
• Swollen lymph nodes, particularly in the neck and armpits
• Severe fatigue

After a few days, the following symptoms may also develop:

• Sore throat, often resembling tonsillitis that does not improve with antibiotics
• General malaise
• Chills
• Excessive sweating
• Loss of appetite and possible mild weight loss
• Puffiness or pain around the eyes
• Swollen tonsils, sometimes with a whitish exudate resembling bacterial plaques
• Joint pain (arthralgia)
• Enlarged spleen (splenomegaly)

Less commonly, some patients may experience:

• Nausea and vomiting
• Jaundice (yellowing of the skin and eyes)
• Difficulty breathing (dyspnea)
• Anemia
• Cardiac arrhythmias, including tachycardia or atrial fibrillation

Fever and sore throat typically resolve within 2 to 3 weeks, while fatigue, swollen lymph nodes, and splenomegaly may persist for several additional weeks.

When mononucleosis is contracted in adulthood, symptoms tend to be more severe and prolonged; fatigue and general malaise may last for several months.

Important drug interaction: Almost all patients who are mistakenly prescribed amoxicillin or ampicillin (due to misdiagnosis as bacterial tonsillitis) develop a widespread maculopapular rash. This reaction is not a true drug allergy; patients do not become permanently allergic to the antibiotic. However, it reinforces the need for accurate diagnosis before prescribing antibiotics.

---

Mononucleosis in Children

In younger children, EBV is often contracted through indirect contact, particularly by placing contaminated objects or toys in the mouth. This behavior is typical of toddlers and young children.

In this age group, the infection frequently runs an asymptomatic or very mild course, resembling a common cold, and resolution is rapid. Adolescents may take slightly longer to recover, potentially a few weeks, but most return to normal activities without complications.

In cases where splenomegaly (an enlarged spleen) is confirmed or suspected, physicians typically recommend avoiding sports for approximately one month, particularly contact sports and physical activities with a risk of abdominal trauma, to prevent the rare but serious risk of splenic rupture.

---

When to See a Doctor

If you or your child experience the symptoms described above, contact your primary care physician for evaluation and diagnosis. In the meantime, rest and adequate hydration are strongly recommended.

Go immediately to the Emergency Department (or call emergency services) if any of the following occur:

• Stridor or difficulty breathing: hoarse breathing or any sign of airway compromise
• Difficulty swallowing liquids, suggesting significant pharyngeal swelling
• Intense abdominal pain, particularly on the upper left side, a potential sign of splenic rupture

These are medical emergencies requiring immediate evaluation.

---

Risks and Complications

For most people, infectious mononucleosis resolves without lasting consequences. However, certain complications, though rare, can be serious.

Prolonged Fatigue

Approximately 1 in 10 patients will experience significant fatigue lasting six months or more after the initial illness. Some experts believe this represents a form of Chronic Fatigue Syndrome (CFS/ME), a poorly understood condition characterized by persistent exhaustion, headaches, and joint pain.

A graded exercise program, which gradually increases physical activity under the guidance of a healthcare professional, can help rebuild energy levels and reduce the duration of prolonged fatigue.

Effects on Blood Cells

EBV infection can temporarily reduce the levels of key blood cells:

• Red blood cells: Anemia, may cause fatigue and shortness of breath
• White blood cells (neutropenia): Reduced immunity, increases susceptibility to secondary infections
• Platelets (thrombocytopenia): Increased bruising and bleeding risk

These changes are usually mild and transient, resolving within a few weeks to months.

Splenic Rupture

Approximately 50% of patients with infectious mononucleosis develop an enlarged spleen (splenomegaly). While this is usually asymptomatic and benign, the enlarged spleen becomes fragile and vulnerable to rupture under physical stress.

The key warning sign of splenic rupture is sudden, severe pain in the upper left abdomen. This is a medical emergency: call 911/emergency services or go immediately to the Emergency Department.

The risk of splenic rupture is estimated at 1 in 500 to 1 in 1,000 cases, but the consequences can be life-threatening due to massive internal hemorrhage. For this reason, all contact sports and strenuous physical activity must be avoided for at least 3 to 4 weeks after symptom onset, or until an ultrasound confirms normalization of splenic size.

Neurological Complications

In fewer than 1 in 100 cases, EBV can affect the nervous system and trigger neurological complications, including:

• Guillain-Barré Syndrome: peripheral nerve inflammation causing numbness, weakness, and temporary paralysis
• Bell’s Palsy: temporary weakness or paralysis of facial muscles on one side
• Viral meningitis: inflammation of the protective membranes around the brain and spinal cord (much less severe than bacterial meningitis)
• Encephalitis: inflammation of the brain itself

These conditions require specific medical management, but more than 80% of affected patients recover fully.

Secondary Bacterial Infection

In a small number of cases, the initial infection temporarily weakens the immune system, creating an opportunity for bacterial superinfection. Potential secondary infections associated with mononucleosis include:

• Bacterial pneumonia
• Pericarditis (infection of the pericardial sac surrounding the heart)

These complications are significantly more common in immunocompromised individuals, such as patients with AIDS or those undergoing chemotherapy.

Lymphoma

Individuals who have had mononucleosis carry a slightly elevated lifetime risk of developing Hodgkin’s lymphoma compared to the general population. However, the absolute risk remains low in the absence of other predisposing factors. The precise biological mechanism linking EBV infection to lymphoma development is still under investigation.

Multiple Sclerosis

Long suspected, this association has now been strongly supported by landmark evidence. A major study published in Science (2022) demonstrated that EBV infection is a necessary precursor for the development of multiple sclerosis (MS).

However, it is critical to contextualize this finding: given the near-universal prevalence of EBV infection globally (~95% of adults), only an extremely small fraction of EBV-infected individuals will ever develop multiple sclerosis. The virus is considered a necessary but not sufficient cause; other genetic and environmental factors are also required.

---

Mononucleosis During Pregnancy

Pregnant women experiencing symptoms resembling mononucleosis should consult their obstetrician immediately, as some cases may actually involve Cytomegalovirus (CMV). This is a closely related herpesvirus that poses a significantly greater risk to the developing fetus than EBV.

In cases of confirmed EBV mononucleosis in pregnancy, current evidence suggests no significant increased risk to the fetus, though vigilant monitoring is always recommended.

---

Diagnosis

The diagnosis of infectious mononucleosis begins with a thorough clinical evaluation. The physician looks for characteristic findings such as pharyngeal inflammation, cervical lymphadenopathy, and splenomegaly. Because the symptoms can overlap substantially with those of bacterial tonsillitis or other viral infections (particularly CMV), laboratory confirmation is essential.

Blood Tests and Biomarkers

The standard diagnostic workup involves two main components:

1. Complete Blood Count (CBC)

• Leukocytosis (elevated white blood cell count) with a predominance of lymphocytes is characteristic
• The presence of atypical lymphocytes (activated immune cells responding to the virus) on peripheral blood smear is a hallmark finding
• Mild anemia (reduced red blood cells) or thrombocytopenia (reduced platelets) may also be present

2. EBV-Specific Serology

This is the gold standard for confirming EBV infection and determining its stage:

3. Monospot Test (Heterophile Antibody Test)

A rapid screening test frequently used in clinical practice. While useful for a quick initial assessment in adolescents and adults, it carries a significant false-negative rate in young children and in the early stages of infection. It should not be used as the sole diagnostic criterion.

4. EBV PCR

In complex cases or immunocompromised patients, the physician may order quantitative PCR for EBV DNA in the blood, a highly sensitive test that directly measures viral load. This is particularly useful when standard serology is inconclusive.

In adults presenting with numerous, large, or treatment-resistant manifestations, additional workup including liver function tests (as transient hepatitis is common in EBV infection) may be indicated.

---

Treatment and Recovery

The primary goal of management is symptom relief and complication prevention. Since mononucleosis is a viral infection, antibiotics are not effective and must not be used unless a confirmed secondary bacterial infection is identified. Currently, no specific antiviral therapy is routinely recommended for uncomplicated EBV mononucleosis.

Therapeutic and Pharmacological Options

Treatment is supportive, tailored to the severity of each patient’s symptoms:

• Fever and pain management: Paracetamol (acetaminophen) or ibuprofen are the first-line choices for managing sore throat and high fever.

  Aspirin must be avoided in children and adolescents due to the risk of Reye’s syndrome, a rare but potentially fatal condition involving liver and brain damage.

• Corticosteroids: The use of corticosteroids is strictly reserved for specific severe complications, including:

  • Airway obstruction due to massively enlarged tonsils
  • Severe hematological complications (profound thrombocytopenia or hemolytic anemia)
  • Neurological involvement

  Routine use of corticosteroids in uncomplicated mononucleosis is not recommended, as it may suppress the immune response without clinical benefit.

• Adequate hydration: Maintaining sufficient fluid intake is essential, as fever increases insensible water losses and difficulty swallowing may discourage drinking. Hydration supports recovery and prevents complications.

Lifestyle and Essential Precautions

Rest is the single most important element of recovery. Fatigue can be profoundly debilitating, and patients should listen to their bodies, returning to activities gradually as energy permits.

Protecting the spleen is a critical safety priority:

• Given the risk of splenomegaly and subsequent rupture, contact sports, heavy lifting, and intense physical exertion must be avoided for a minimum of 3 to 4 weeks from symptom onset
• Return to sport should only occur after medical clearance, ideally with ultrasound confirmation of splenic normalization

Alcohol should be avoided during the acute phase of illness, as the liver is frequently involved (mild transient hepatitis is common with EBV infection), and alcohol may exacerbate hepatic inflammation.

Driving and operating machinery should be temporarily avoided if fatigue is severe enough to impair alertness and reaction time.

---

Prevention

Infectious mononucleosis spreads primarily through saliva. If you are infected, the following measures can help reduce the risk of transmission:

• Avoid kissing others while symptomatic, and for several days after fever resolves
• Do not share food, plates, glasses, cutlery, or drinking bottles
• Do not share toothbrushes
• Be aware that EBV can continue to be shed in saliva for months after recovery, and the virus remains latent in the body for life. Periodic silent reactivation and transmission can occur even without symptoms

There is currently no licensed vaccine available to prevent EBV infection, though research in this area is ongoing.

---

Frequently Asked Questions

What is infectious mononucleosis?

Infectious mononucleosis, also called the “kissing disease” or glandular fever, is a contagious viral illness caused by the Epstein-Barr virus (EBV). It typically produces mild symptoms in children but can cause more severe and prolonged illness in adolescents and adults. Transmission occurs primarily through saliva.

What is the incubation period?

Approximately 4 to 6 weeks in adolescents and adults. In younger children, the incubation period may be shorter.

What are the main symptoms?

The most common symptoms of infectious mononucleosis are:

• Severe fatigue
• Sore throat (often resembling tonsillitis)
• Fever
• Swollen and tender lymph nodes in the neck
• Enlarged tonsils
• Headache
• Splenomegaly (enlarged spleen)

How long does mononucleosis last?

In children and teenagers, the infection may be asymptomatic or produce only mild symptoms lasting less than two weeks. In adults, certain symptoms, particularly fatigue, can persist for several months. In rare cases, prolonged fatigue may continue for six months or more.

How is it transmitted?

The virus spreads through saliva, either directly via kissing or indirectly via shared utensils, glasses, or other objects that come into contact with saliva. It is considered less contagious than many other viral illnesses such as the common cold or influenza.

How is mononucleosis treated?

There is no specific antiviral treatment. Management is symptomatic: rest, adequate hydration, and analgesics/antipyretics (paracetamol or ibuprofen) to manage fever and pain. Aspirin must be avoided in children due to the risk of Reye’s syndrome. Antibiotics are ineffective and should not be used unless a secondary bacterial infection is confirmed.

What should I eat during mononucleosis?

No specific diet is required. A healthy, varied, and balanced diet is recommended, the same as for the general population. Staying well hydrated is particularly important. Alcohol should be strictly avoided, as it can worsen the liver inflammation that commonly accompanies EBV infection.

Can you get mononucleosis more than once?

In general, no, most people contract mononucleosis only once, after which the immune system maintains long-term control of the virus. However, EBV remains latent in the body for life and can reactivate silently, potentially making a person intermittently contagious even without symptoms. Symptomatic recurrence is rare but possible, particularly in immunocompromised individuals.

When is it safe to return to sport after mononucleosis?

Return to sport, especially contact sports, should only occur after a minimum of 3 to 4 weeks from symptom onset and only with medical clearance. Given the risk of splenic rupture, many clinicians recommend an abdominal ultrasound to confirm that the spleen has returned to normal size before resuming strenuous physical activity. Your doctor will provide individualized guidance based on your clinical picture.

---

Sources and Bibliography

• National Health Service (NHS). Glandular Fever (Infectious Mononucleosis). https://www.nhs.uk/conditions/glandular-fever/
• Centers for Disease Control and Prevention (CDC). Epstein-Barr Virus and Infectious Mononucleosis. https://www.cdc.gov/epstein-barr/about/index.html
• Balfour HH Jr, Dunmire SK, Hogquist KA. Infectious mononucleosis. Clin Transl Immunology. 2015;4(2):e33. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346501/
• Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296–301. https://www.science.org/doi/10.1126/science.abj8222
• Harvard Health Publishing. Infectious Mononucleosis A to Z. https://www.health.harvard.edu/a_to_z/infectious-mononucleosis-a-to-z
• American Cancer Society. Risk Factors for Hodgkin Lymphoma. https://www.cancer.org/cancer/types/hodgkin-lymphoma/causes-risks-prevention/risk-factors.html